# Deferasirox

NDC: 69539-074
Generic name: Deferasirox
Labeler / Manufacturer: MSN LABORATORIES PRIVATE LIMITED
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200616

FDA application: ANDA210945

## Active ingredients

- DEFERASIROX: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69539-074"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69539-074
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0354cbc7-9b32-4513-976a-2ef2da39b6b3